Drug Development Pipeline NewsLatest News On Drug Development Pipeline New Hope for Antimicrobial Peptides?12/12/2024 3:21 AM Better Amyloidosis Treatments Expand Options and Cures12/6/2024 4:45 AM New Pill Successfully Lowers Lp(a) Levels11/19/2024 12:06 AM Europe Rejects Cinainu (Alopecia) and Kizfizo (Neuroblastoma)11/15/2024 11:42 AM Leqembi Okayed for Subset of Early Alzheimer’s Patients11/15/2024 10:34 AM Two Lung Cancer Drugs Recommended by EMA11/15/2024 10:34 AM EMA OKs Sublingual Formulation for Opioid Dependence10/18/2024 9:55 AM EMA Authorizes Korjuny for Malignant Ascites10/18/2024 8:41 AM Hympavzi Approved in Europe for Severe Hemophilia A and B9/20/2024 10:43 AM EMA Backs Approval of Elahere for Ovarian Cancer9/20/2024 9:46 AM Two New Drugs Approved for Age-Related Macular Degeneration9/20/2024 9:45 AM FDA Approves Lebrikizumab for Atopic Dermatitis9/14/2024 9:01 AM Assessing the Impact of FDA Accelerated Approval in Oncology9/11/2024 9:59 AM Impressive Results With Gene Silencer in ATTR-Cardiomyopathy9/9/2024 2:17 PM Canada Moves Toward 'Agile' Drug, Device Approval8/19/2024 8:08 AM Anzupgo Approved in Europe for Severe Hand Eczema7/26/2024 9:47 AM EU Backs Drug to Relieve Itching in Alagille Syndrome7/26/2024 9:47 AM EMA Backs Oral Drug for Primary Biliary Cholangitis7/26/2024 8:50 AM EMA Refuses Marketing Authorization for Alzheimer's Drug7/26/2024 8:50 AM Novel Gene Therapy Safe for Retinitis Pigmentosa7/23/2024 4:27 AM
